Drug
Gsk5471713
Gsk5471713: highest development phase Phase 1/2, developed by GlaxoSmithKline. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| GSK5471713 NCT07332455 | Phase 1/2 | Neoplasms, Prostate |
Latest
No recent events.
Follow Gsk5471713 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.